SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-030496
Filing Date
2024-08-07
Accepted
2024-08-07 09:05:12
Documents
15
Period of Report
2024-08-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53696
2 ex3-1.htm EX-3.1 13418
  Complete submission text file 0001493152-24-030496.txt   292233

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cing-20240802.xsd EX-101.SCH 3781
4 XBRL DEFINITION FILE cing-20240802_def.xml EX-101.DEF 26635
5 XBRL LABEL FILE cing-20240802_lab.xml EX-101.LAB 36718
6 XBRL PRESENTATION FILE cing-20240802_pre.xml EX-101.PRE 25259
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5831
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 241181770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)